StonvexLoading…
StonvexCore line items from MRCY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-27 | Q4 2025 2025-12-26 | Q3 2025 2025-09-26 | Annual 2025 2025-06-27 |
|---|---|---|---|---|---|
Revenue | $279.14M | $693.84M | $458.08M | $225.21M | $912.02M |
Operating Income | Not available | $-14.19M | $-19.41M | $-8.60M | $-19.63M |
Net Income | Not available | $-30.47M | $-27.61M | $-12.52M | $-37.90M |
EPS (Diluted) | $0.42 | $-0.51 | $-0.47 | $-0.21 | $-0.65 |
Total Assets | Not available | $2.48B | $2.50B | $2.46B | $2.43B |
Total Liabilities | Not available | $1.00B | $1.04B | $982.58M | $961.30M |
Cash & Equivalents | Not available | $331.80M | $334.99M | $304.72M | $309.10M |
Free Cash Flow OCF − CapEx | Not available | $39.52M | $41.34M | $-4.37M | $119.05M |
Shares Outstanding | Not available | 59.50M | 59.38M | 59.43M | 59.00M |